|
MKL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.42670361372666E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.31129995540169E-09 |
| Normal-vs-Stage2 |
2.156700E-03 |
| Normal-vs-Stage3 |
2.80329981450222E-10 |
| Normal-vs-Stage4 |
1.08700048961907E-10 |
| Stage1-vs-Stage2 |
1.805170E-01 |
| Stage1-vs-Stage3 |
6.882000E-02 |
| Stage1-vs-Stage4 |
4.944900E-03 |
| Stage2-vs-Stage3 |
1.788220E-02 |
| Stage2-vs-Stage4 |
4.178700E-03 |
| Stage3-vs-Stage4 |
3.150800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.65570043523189E-10 |
| Normal-vs-AfricanAmerican |
6.16460000000263E-05 |
| Normal-vs-Asian |
2.41550000001922E-07 |
| Caucasian-vs-AfricanAmerican |
7.643200E-01 |
| Caucasian-vs-Asian |
6.488600E-01 |
| AfricanAmerican-vs-Asian |
9.688800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57269997025367E-09 |
| Normal-vs-Female |
5.78350034530217E-10 |
| Male-vs-Female |
7.003000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29059999856673E-08 |
| Normal-vs-Age(41-60Yrs) |
3.15869996825313E-09 |
| Normal-vs-Age(61-80Yrs) |
2.11799999760842E-08 |
| Normal-vs-Age(81-100Yrs) |
1.522800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.252200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.608200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.802200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.449400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.178200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.568000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.88750000002158E-06 |
| Classical-VS-Follicular |
5.396200E-01 |
| Classical-VS-Other |
1.267780E-01 |
| Classical-VS-Normal |
2.11489999957237E-08 |
| Tall-VS-Follicular |
9.584100E-04 |
| Tall-VS-Other |
8.365400E-01 |
| Tall-VS-Normal |
4.30655511252098E-12 |
| Follicular-VS-Other |
2.160400E-01 |
| Follicular-VS-Normal |
8.26389999986077E-07 |
| Other-VS-Normal |
8.359300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74889999984929E-07 |
| Normal-vs-N1 |
5.15550002688769E-09 |
| N0-vs-N1 |
7.098400E-02 |
|
|
